<i>Meta-analysis:</i> Potentials and promise
BMJPublished 22 November 1997Open access
Matthias Egger, George Davey Smith
Citations647
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The potentials and promise of meta-analysis of randomised controlled trials and various extensions beyond the calculation of a combined estimate are examined.
Keywords
Decision SciencesNeuroscienceHealth Professions
BMJBias in meta-analysis detected by a simple, graphical test
56,268 Citations1997Matthias Egger, George Davey Smith +2 more
Funnel plots, plots of the trials' effect estimates against sample size, are skewed and asymmetrical in the presence of publication bias and other biases Funnel plot asymmetry, measured by regression analysis, predicts discordance of results when meta-analyses are compared with single large trials.
Progress in Cardiovascular DiseasesBeta blockade during and after myocardial infarction: An overview of the randomized trials
3,239 Citations1985Salim Yusuf, Richard Peto +3 more
The aim has been not only to review the 65-odd randomized beta blocker trials but also to demonstrate that when many randomized trials have all applied one general approach to treatment, it is often not appropriate to base inference on individual trial results.
The LancetEFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION
2,451 Citations1986GRUPPOITALIANOPERLOSTUDIODELL
BMJMeta-analysis: Principles and procedures
2,400 Citations1997Matthias Egger, George Davey Smith +1 more
These principles are discussed, along with the practical steps in performing meta-analysis, which allow a more objective appraisal of the evidence than traditional narrative reviews, provide a more precise estimate of a treatment effect, and may explain heterogeneity between the results of individual studies.
Journal of the American Medical AssociationTHE POWERFUL PLACEBO
1,810 Citations1955Henry K. Beecher
It is interesting that Pepper could say as recently as 10 years ago "apparently there has never been a paper published discussing the important subject of the placebo," but in 1953 Gaddum1 said: Such tablets are sometimes called placebos, but it is better to call them dummies.
Epidemiologic ReviewsQUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1
1,655 Citations1987Sander Greenland
New England Journal of MedicineThe Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control Trial
1,641 Citations1978Jennie A. Freiman, Thomas C. Chalmers +2 more
JAMAA Comparison of Results of Meta-analyses of Randomized Control Trials and Recommendations of Clinical Experts
1,464 Citations1992Elliott M. Antman
Finding and analyzing all therapeutic trials in a given field has become such a difficult and specialized task that the clinical experts called on to summarize the evidence in a timely fashion need access to better databases and new statistical techniques to assist them.
BMJ<i>meta-analysis</i> bias in location and selection of studies
1,383 Citations1998Matthias Egger, George Davey Smith
New England Journal of MedicineCumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction
1,141 Citations1992Joseph Lau, Elliott M. Antman +4 more
Cumulative meta-analysis of therapeutic trials facilitates the determination of clinical efficacy and harm and may be helpful in tracking trials, planning future trials, and making clinical recommendations for therapy.
BMJ<i>Meta-analysis</i> Spurious precision? Meta-analysis of observational studies
980 Citations1998Matthias Egger, Marc P. Schneider +1 more
A Medline search identified 566 articles published in 1995 and indexed with the medical subject heading (MeSH) term “meta-analysis” and randomly selected 100 articles, finding about half were based on observational studies, mainly cohort and case-control studies of medical interventions or aetiological associations.
New England Journal of MedicineEffects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer
934 Citations1988Early Breast Cancer Trialists' Collaborative Group
This overview was able to demonstrate particularly clearly that both tamoxifen and cytotoxic therapy can reduce five-year mortality, and showed that combination chemotherapy was significantly more effective than single-agent therapy.
Annals of Internal MedicineThe Medical Review Article: State of the Science
854 Citations1987Cynthia D. Mulrow
It is indicated that current medical reviews do not routinely use scientific methods to identify, assess, and synthesize information.
The LancetLow-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis
673 Citations1992Michael T. Nurmohamed, Harry R. Büller +6 more
There is at present no convincing evidence that in general surgery patients LMWHs, compared with standard heparin, generate a clinically important improvement in the benefit to risk ratio, but LM WHs may be preferable for orthopaedic surgery patients, in view of the larger absolute risk reduction for venous thrombosis.
Epidemiologic ReviewsMeta-analysis: State-of-the-Science
499 Citations1992Kay Dickersin, Jesse A. Berlin
Arthritis & RheumatismThe comparative efficacy and toxicity of second‐line drugs in rheumatoid arthritis results of two metaanalyses
472 Citations1990David T. Felson, Jennifer J. Anderson +1 more
Of the commonly used second-line drugs, AUR is the weakest, and injectable gold is the most toxic, and agents introduced in the future will be compared with these drugs.
Medical Entomology and ZoologyStatistical Inference: A Commentary for the Social and Behavioural Sciences
392 Citations1986Michael W. Oakes
BMJGetting to grips with Archie Cochrane's agenda.
383 Citations1992Iain Chalmers, Kay Dickersin +1 more
The results quantify a trigger leading to rapid, drought-induced die-off of overstory woody plants at subcontinental scale and highlight the potential for such die-offs to be more severe and extensive for future global-change-type drought under warmer conditions.
BMJLow molecular weight heparin in prevention of perioperative thrombosis.
379 Citations1992Alain Leizorovicz, M. Haugh +3 more
Low molecular weight heparins seem to have a higher benefit to risk ratio than unfractionated heparin in preventing perioperative thrombosis and it remains to be shown in a suitably powered clinical trial whether low molecular weight Heparin reduces the risk of fatal pulmonary embolism compared withHeparin.
JAMAThe Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care
377 Citations1995Lisa Bero
BMJCholesterol lowering trials in coronary heart disease: frequency of citation and outcome.
313 Citations1992Uffe Ravnskov
Lowering serum cholesterol concentrations does not reduce mortality and is unlikely to prevent coronary heart disease and claims of the opposite are based on preferential citation of supportive trials.
Journal of the American Statistical AssociationMedical Uses of Statistics.
297 Citations1989Richard G. Cornell, Fredric M. Wolf +2 more
JAMAMinimizing the Three Stages of Publication Bias
225 Citations1990Thomas C. Chalmers
Bias can be minimized by insisting on high-quality research and thorough literature reviews, eliminating the double standard concerning peer review and informed consent applied to clinical research and practice, and publishing legitimate trials regardless of their results.
BMJMeta-analysis and the meta-epidemiology of clinical research
210 Citations1997C. David Naylor
This week's BMJ contains a pot-pourri of materials that deal with the research methodology of meta-analysis, with many studies have documented publication bias favouring clinical trials that show a significant treatment effect.
BMJMeta-analysis: Unresolved issues and future developments
176 Citations1998George Davey Smith, Matthias Egger
In this final article of the series, some of the topics that are likely to feature in future discussions of the appropriate practice and domain of meta-analysis are addressed.
BMJMeta-analysis: Beyond the grand mean?
174 Citations1997George Davey Smith, Matthias Egger +1 more
This article examines how to use meta-analysis to do more than simply combine the results from all the individual trials into a single effect estimate, and discusses the advantages and disadvantages of performing subgroup analyses.
Journal of Clinical EpidemiologyMeta-analysis in medicine Where we are and where we want to go
144 Citations1989Milos Jenicek
The greatest challenge of meta-analysis in medicine lies in the integration of the qualitative and quantitative assessment of given information (scoring of quality, weighing of the effect size by quality score, etc.).
Journal of the American Pharmaceutical Association (1961)United States District Court for the District of Columbia
73 Citations1974
BMJPromoting clinical effectiveness
66 Citations1996J.K. Hayward
Britain's NHS Executive seems determined to encourage an evidence based and evaluative approach to clinical decision making, but many health professionals may think that the promotion of effective clinical policy would be even more welcome if it were matched by anEvidence based culture in other areas of government health policy.
BMJCholesterol and total mortality: need for larger trials.
62 Citations1992Rory Collins, Anthony Keech +8 more
It has been suggested that the current trials of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors can be expected to provide reliable evidence on the effects of lowering blood cholesterol concentration on total mortality, but these trials are, however, designed primarily to assess the effect oflowering cholesterol concentration only on coronary heart disease.
Pharmacotherapy The Journal of Human Pharmacology and Drug TherapyMeta‐Analysis: Whither Narrative Review?
54 Citations1989J. Russell Teagarden
Meta‐analysis refers to methodologies that are used to integrate related empirical research to arrive at conclusions not possible by reviewing individual studies, or to improve generalizations of individual studies.
Statistics in MedicineInterpretation of results from subset analyses within overviews of randomized clinical trials
37 Citations1987Richard D. Gelber, Aron Goldhirsch
Overviews, by providing evidence based on large numbers of patients, can be useful for overcoming the difficulties of detecting therapeutic effects within subsets of patients but inconsistent subset definitions, misclassification of Patients, and incomplete availability of patient subsets from the trials included in the overview bias the estimates of effect size.
The Importance of Beta, the Type II Error, and Sample Size in the Design and Interpretation of the Randomized Controlled Trial
35 Citations2019Jennie A. Freiman, Thomas C. Chalmers +2 more
Journal of Clinical EpidemiologyMeta-analysis of second-line antirheumatic drugs: sample size bias and uncertain benefit
26 Citations1992Peter C Gøtzsche
It is concluded that the benefit of second-line drugs is uncertain and no evidence of a worthwhile effect on radiological changes was found.